BriefMD

Specialties / Pediatrics

New Pediatrics research.

The strongest recent Pediatrics papers on PubMed, ranked by study design, topic and journal, with the same summaries subscribers get.

  1. randomized trial, 166 patients

    Emotion-Focused Behavioral Weight Loss Treatment for Adolescents: A Randomized Clinical Trial

    Boutelle KN, Manzano MA, Pasquale EK, et al. JAMA Netw Open. Oct 2026.

    Findings
    The trial of 166 dyads found no significant difference in post‑treatment weight loss (difference in BMIz = 0.03). However, at 12 months the emotion‑regulation group regained less weight (difference in BMIz = ‑0.09) and a higher proportion achieved clinically significant loss (22% vs 4%).
    Bottom line
    Adding emotion‑regulation to FBT may reduce weight regain (BMIz ‑0.09) and increase clinically significant loss (22% vs 4%).

    PubMed, PMID 42911592

  2. randomized trial, 595 patients

    Telemedicine Consultation for Pediatric Trauma in Community ED Visits and Parent Experience of Care: A Stepped-Wedge Cluster-Randomized Clinical Trial

    Marcin JP, Rosenthal JL, Tancredi DJ, et al. JAMA Netw Open. Oct 2026.

    Findings
    Telemedicine consultation did not significantly alter overall parent experience of care (AMD, 0.041; P = .10) or parent distress (AMD, -0.031; P = .82). However, discharge and transfer experience ratings were higher with telemedicine (AMD, 0.104; P = .01).
    Bottom line
    Routine pediatric trauma telemedicine did not significantly reduce parent distress or transfer odds (aOR 0.59; P = .43), though transition care ratings improved.

    PubMed, PMID 42905708

  3. randomized trial, 76 patients

    Optimization of Anticoagulation Strategy During Cardiopulmonary Bypass in Neonates with Congenital Heart Disease: A Randomized Controlled Trial

    Wang H, Liu Q, Gao P, et al. Drug Des Devel Ther. Jan 2026.

    Findings
    In a randomized controlled trial, 76 neonates undergoing cardiopulmonary bypass were assigned to receive an initial heparin dose of either 600 U/kg (n = 38) or 400 U/kg (n = 38).
    Bottom line
    Both dosing groups included 38 participants, with total enrollment of 76 neonates.

    PubMed, PMID 42899169

  4. randomized trial, 155 patients

    Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial

    Freitas IOP, Schuartz I, Renz GLK, et al. Support Care Cancer. Oct 2026.

    Findings
    In a single‑blind RCT, 155 patients aged 1‑18 years receiving high‑dose methotrexate were randomized to intraoral photobiomodulation (PBM‑IO, n = 73) or extraoral photobiomodulation (PBM‑EO, n = 82). Overall oral mucositis occurred in 35.5% of participants, with 41.1% in the PBM‑IO group and 30.5% in the PBM‑EO group (p = 0.168).
    Bottom line
    Both intraoral and extraoral PBM showed similar efficacy, with no statistically significant difference in oral mucositis rates (p = 0.168).

    PubMed, PMID 42897331

Summaries are written by AI from PubMed abstracts, for keeping up with the literature. Check the source before it changes care. Editorial policy · Medical disclaimer

Get Pediatrics research every morning.

Free. Choose your Pediatrics topics after you subscribe.